Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1

Cancer Lett. 2007 Feb 8;246(1-2):300-7. doi: 10.1016/j.canlet.2006.03.009. Epub 2006 Apr 18.

Abstract

We recently reported that schisandrin B (Sch B) was a novel P-glycoprotein (P-gp) inhibitor. In this study, we revealed that Sch B was also an effective inhibitor of multidrug resistance-associated protein 1 (MRP1). The activities of Sch B to reverse MRP1-mediated drug resistance was tested using HL60/ADR and HL60/MRP, the human promyelocytic leukemia cell lines with the overexpression of MRP1 but not P-gp. Sch B resumed daunorubicin and carboxyfluorescein diacetate (CFDA, a specific substrate for MRP1) accumulation and retention in HL60/ADR cells in a time and concentration dependent manner. At the equimolar concentration, Sch B demonstrated significantly stronger potency than probenecid, a MRP1 inhibitor. This study, together with the previous findings, demonstrated that Sch B was a dual inhibitor of P-gp and MRP1, a type suggested to be preferable to the use of combination of two specific modulators to prevent drug-drug interaction and cumulative toxicities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / antagonists & inhibitors*
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism
  • Antibiotics, Antineoplastic / metabolism
  • Antibiotics, Antineoplastic / pharmacology
  • Cyclooctanes / chemistry
  • Cyclooctanes / pharmacology
  • Daunorubicin / metabolism
  • Daunorubicin / pharmacology
  • Dose-Response Relationship, Drug
  • Doxorubicin / pharmacology
  • Drug Resistance, Multiple / drug effects
  • Drug Resistance, Neoplasm / drug effects
  • Flow Cytometry
  • Fluoresceins / administration & dosage
  • Fluoresceins / metabolism
  • Gene Expression Regulation, Neoplastic
  • HL-60 Cells
  • Humans
  • Lignans / chemistry
  • Lignans / pharmacology*
  • Molecular Structure
  • Multidrug Resistance-Associated Proteins / antagonists & inhibitors*
  • Multidrug Resistance-Associated Proteins / genetics
  • Multidrug Resistance-Associated Proteins / metabolism
  • Polycyclic Compounds / chemistry
  • Polycyclic Compounds / pharmacology*
  • Probenecid / pharmacology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Antibiotics, Antineoplastic
  • Cyclooctanes
  • Fluoresceins
  • Lignans
  • Multidrug Resistance-Associated Proteins
  • Polycyclic Compounds
  • RNA, Messenger
  • carboxyfluoresceindiacetate
  • schizandrin B
  • Doxorubicin
  • Probenecid
  • multidrug resistance-associated protein 1
  • Daunorubicin